Alta Advisers’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$228K Hold
2,670
0.08% 179
2025
Q4
$211K Sell
2,670
-1,200
-31% -$94.1K 0.08% 186
2025
Q3
$309K Hold
3,870
0.09% 169
2025
Q2
$352K Hold
3,870
0.13% 150
2025
Q1
$363K Buy
3,870
+1,100
+40% +$98.5K 0.15% 134
2024
Q4
$252K Buy
2,770
+470
+20% +$44.9K 0.16% 123
2024
Q3
$239K Hold
2,300
0.11% 119
2024
Q2
$223K Hold
2,300
0.11% 114
2024
Q1
$207K Hold
2,300
0.1% 125
2023
Q4
$183K Hold
2,300
0.1% 127
2023
Q3
$164K Hold
2,300
0.09% 130
2023
Q2
$177K Hold
2,300
0.1% 121
2023
Q1
$173K Hold
2,300
0.1% 117
2022
Q4
$181K Hold
2,300
0.11% 107
2022
Q3
$162K Buy
+2,300
New +$180K 0.1% 107
2013
Q4
Sell
-464
Closed -$28K 51
2013
Q3
$28K Sell
464
-284
-38% -$16.8K 0.01% 52
2013
Q2
$43K Buy
+748
New +$44.4K 0.02% 67

Other funds holding CL

Alta Advisers's CL Position: Q1 2026 in Review

Alta Advisers held its Colgate-Palmolive (CL) position steady in Q1 2026 at 2,670 shares worth $228K. The position accounts for 0.08% of the portfolio, ranked #179.

Alta Advisers first reported a position in CL in Q2 2013 and has held it in 17 quarters since. The position peaked at $363K in Q1 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Alta Advisers held 2,670 shares of Colgate-Palmolive worth $228K as of Q1 2026.
  • Alta Advisers left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.08% of Alta Advisers's portfolio in Q1 2026, its #179 holding.
  • Alta Advisers first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 17 quarters since.
  • Alta Advisers's Colgate-Palmolive position peaked at $363K in Q1 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Alta Advisers's 13F filing for Q1 2026, filed 7 May 2026.